Skip to main content
Scientific Reports logoLink to Scientific Reports
. 2021 Sep 29;11:19325. doi: 10.1038/s41598-021-98887-9

A reproducible method for biochemical, histological and functional assessment of the effects of ischaemia–reperfusion syndrome in the lower limbs

Iñigo Cearra 1,2,3, Borja Herrero de la Parte 2,3,, Diana Isabel Moreno-Franco 4, Ignacio García-Alonso 2,3
PMCID: PMC8481548  PMID: 34588582

Abstract

Current methodology described to mimic lower limb ischaemia–reperfusion injury (LL-IRI) does not accurately define the procedures and pressures exerted to induce and maintain ischaemia. In this piece of work, we propose a well-defined and detailed rat model that simulates the conditions established in clinical practice guidelines for tourniquet application and allows us to test treatments that aim to prevent/reduce LL-IRI. Eighty-six male WAG/RijHsd rats were subjected to hind limb IRI (LL-IRI), using a mechanical system applying a 1 kg tension to induce and maintain ischemia for 2 or 3 h, and assessed the damage caused by reperfusion at biochemical and muscular levels at different time points. At the biochemical level, both 2 and 3 h of ischemia induced changes (except for electrolyte levels); 3 h of ischemia induced greater changes in specific markers of muscular damage: creatine kinase (CK) and lactate dehydrogenase (LDH). At the histopathological level, 3 h of ischemia and 24 h of reperfusion was associated with an increase in hind limb girth, cross-sectional area, and weight and presence of neutrophils, as well as histological damage in more than 60% of muscle fibres. Our model allows to reliably reproduce the damage associated with the use of a pneumatic tourniquet. CK and LDH, as well as measures of tissue damage, allow to define and characterize the response to LL-IRI-related damage. A period of 3 h of ischemia followed by 3 h of reperfusion caused only local damage but showed greater sensitivity to detect differences in future studies on prophylactic treatments against LL-IRI.

Subject terms: Diseases, Preclinical research, Experimental models of disease

Introduction

Tourniquet-induced ischemia lasting for 1–2 h, or exceptional cases as long as 3 h, commonly achieved using a pneumatic cuff, is currently a routine process in extremity surgery, especially in orthopaedic surgery, allowing to obtain a bloodless surgical field, which facilitates surgical manoeuvres. However, its use entails a local ischemia/reperfusion injury (IRI). IRI has been widely described and studied in numerous sites and tissue types. Briefly, it is a systemic immune response, triggered by the release of proinflammatory mediators and reactive oxygen species during reperfusion of an organ or tissue that has undergone some period of ischaemia. This damage, due to immune activation during reperfusion, is actually greater than that caused by the ischemia itself1,2.

The clinical use of tourniquet cuffs has been associated with increased postoperative pain up to 2–6 weeks3,4. Further, greater swelling has been observed at 25 and 66weeks after surgery when tourniquet cuffs were used. Moreover, from a functional point of view, significantly poorer range of motion (ROM), and greater postoperative weakness of the quadriceps several weeks after the tourniquet was applied have been described48.

Several animal models of lower limb Ischaemia–reperfusion injury (LL-IRI) have been described to conduct experimental studies on these issues. However, there is poor consensus among them, both in terms of the animal model, the methodology employed, and the detailed description of the methodology, referring to them as "previously described by other authors". Literature on techniques for inducing LL-IRI includes invasive surgical procedures, involving muscle disinsertion and surgical excision or clamping of the femoral vessels9,10, to tourniquet models based on the application of a non-loosening nylon cable tie11, or rubber or latex bands1219, used either in rats or mice. Both elastic tourniquets and high pressure levels applied with a uncontrolled tension tourniquet, such as rubber ring, increase both the frequency and severity of tourniquet-induced local injuries20,21. Among these animal models, only those models described by Bonheur18 and Drysch19 apply a model that is similar to that used in clinical practice, which uses the minimal limb occlusion pressure (MLOP), defined as the pressure in the tourniquet at which the distal arterial blood flow, as assessed by a Doppler probe held over a distal artery, is occluded.

An additional point of contention is whether ischaemia is performed on one (unilateral) or both (bilateral) limbs at the same time. Since, in the clinical settings, bilateral knee surgery might carry higher rates of blood transfusion, postoperative complications, increased incidence of 90-day mortality, venous or pulmonary thromboembolism and neurological complications2224, it seems that bilateral models might further increase damages, masking the effects of the LL-IRI itself.

In preclinical research, imprecise description of some crucial aspects for the experiments, such as proper methodological description and specification of all the parameters, is a major obstacle to ensure its reproducibility25. Recently, in 2019, Sansa urged researchers to be more explicit and to publish ever more detailed experimental protocols, which allow others to repeat experiments. Moreover, he concluded that this "reproducibility crisis" could eventually undermine the general public's confidence in biomedical research, which might entail other unfortunate consequences26.

With that background, this piece of work details an experimental model in rats, based on several aspects of those already described by other authors, but closer to clinical practice, using a controlled tension system, as well as techniques and times similar to those employed in clinical practice. To quantify the LL-IRI, we have chosen those biochemical and histopathological parameters most related to the clinical use, among the many described in the scientific literature, and we have studied the best time of reperfusion to assess them. Additionally, we have also carried out physical studies to assess the degree of functional recovery after controlled ischaemia.

Results

Validation of the ischemia-inducing system

All the procedures were well-tolerated, and no adverse events were reported. After applying an increasing tensile force ranging from 0.5 to 1 kg (with 0.1 kg increments), we found that it was necessary to apply 1 kg to achieve and maintain ischemia in 100% of the animals (Fig. 1A). These findings were confirmed both by the clinical signs described, but also by laser Doppler flow measurement (Fig. 1B).

Figure 1.

Figure 1

Percentage of animals developing ischemia under different tensile forces (A). Measurement of flow in the pedis artery territory in animals subjected to ischemia at 1 kg of tensile force (B).

Biochemical assessment of LL-IRI

The results concerning the biochemical parameters studied are presented in Table 1 and Fig. 2. In general, it can be seen that the greatest damage was seen in animals subjected to 3 h of ischemia, followed by 3 h of reperfusion.

Table 1.

Results of biochemical analysis and levels of electrolytes in serum.

Group Na+ (mEq/L) K+ (mEq/L) Cl (mEq/L) Urea (mg/dL) Creatinine (mg/dL) ALP (U/L) AST (U/L) ALT (U/L) CK (U/L) LDH (U/L)
Control 146.7 ± 0.95 4 ± 0.45 103.7 ± 1.5 28 ± 3.2 0.36 ± 0.065 122 ± 5.06 51.43 ± 2.64 41.71 1.604 82.17 ± 9.41 44.83 ± 18.81
IR-1 143.0 ± 4.18 n.s 4.68 ± 0.29 n.s 99.8 ± 4.76 n.s 39.60 ± 5.36 p < 0.05 0.648 ± 0.19 p < 0.05 91.60 ± 26.6 p < 0.01 114.8 ± 45.94 n.s 52.50 ± 2.77 n.s 3168 ± 1314 p < 0.01 480 ± 199 p < 0.01
IR-2 142.9 ± 3.02 n.s 4.68 ± 0.36 n.s 100.1 ± 3.62 n.s 43.86 ± 6.01 p < 0.01 0.539 ± 0.12 p < 0.05 89.17 ± 26.7 p < 0.0001 128.0 ± 21.44 n.s 55.50 ± 0.55 n.s 4025 ± 629.7 p < 0.001 515 ± 166 p < 0.01
IR-3 144.5 ± 3.08 n.s 4.83 ± 0.64 n.s 99.5 ± 2.88 n.s 68.33 ± 3.61 p < 0.001 0.633 ± 0.20 p < 0.05 107.0 ± 14.68 n.s 321.5 ± 76.38 p < 0.001 81.33 ± 10.26 p < 0.0001 6429 ± 2007 p < 0.0001 1015 ± 310.8 p < 0.0001
IR-4 142.3 ± 2.93 n.s 4.5 ± 0.63 n.s 97.8 ± 3.96 n.s 64.29 ± 16.3 p < 0.001 0.428 ± 0.14 n.s 96.39 ± 36.44 n.s 188.67 ± 104.0 p < 0.001 73.67 ± 18.50 p < 0.0001 3872 ± 1834 p < 0.001 609 ± 250.8 p < 0.001
IR-5 147.2 ± 1.92 n.s 4.38 ± 0.57 n.s 102.6 ± 1.52 n.s 43.0 ± 8.09 p < 0.05 0.64 ± 0.15 n.s 122.8 ± 17.77 n.s 156.8 ± 70.33 p < 0.05 67.20 ± 18.10 n.s 4870 ± 1623 p < 0.001 770.4 ± 376.4 p < 0.01
IR-6 145.7 ± 2.29 n.s 4.59 ± 0.36 n.s 102.4 ± 3.1 n.s 50.0 ± 7.81 p < 0.001 0.80 ± 0.23 p < 0.01 117.66 ± 11.91 n.s 174.1 ± 69.43 p < 0.01 66.86 ± 21.73 n.s 6042 ± 2570 p < 0.0001 844.0 ± 328.2 p < 0.01
IR-7 142.7 ± 1.75 n.s 4.27 ± 0.37 n.s 99.3 ± 2.06 n.s 64.8 ± 9.91 p < 0.001 0.88 ± 0.31 p < 0.001 122.5 ± 19.17 n.s 391.8 ± 72.0 p < 0.001 90.33 ± 13.19 p < 0.001 9459 ± 1467 p < 0.0001 1395 ± 262.4 p < 0.0001
IR-8 144.3 ± 2.8 n.s 4.52 ± 0.17 n.s 101.7 ± 1.86 n.s 64.2 ± 15.8 p < 0.001 0.55 ± 0.17 n.s 127.16 ± 37.18 n.s 307.5 ± 93.35 p < 0.001 79.00 ± 26.1 p < 0.01 4858 ± 2392 p < 0.001

937.5 ± 393.3

p < 0.001

Data are presented as the mean, the corresponding standard deviation (SD) and the p value from comparison with the reference value of the control group (first line), considering p values < 0.05 to be significant. ALP alkaline phosphatase, AST aspartate aminotransferase, ALT alanine aminotransferase, CK creatine kinase, LDH lactate dehydrogenase.

Figure 2.

Figure 2

Measurements of serum electrolytes and enzymes of animals exposed to 2 h (circles, solid line) or 3 h (triangles, dashed lines) of ischemia and different periods of reperfusion. Na + (A), K + (B), Cl− (C), urea (D), creatinine (E), ALP (F), AST (G), ALT (H), CK (I) and LDH (J). Units are milliequivalents per litre (mEq/L) for Na+, K+ and Cl, mg/dL for urea and creatinine, and international units per litre (U/L) for ALP, AST, ALT, CK, and LDH. The asterisks indicate statistically significant differences when comparing the two durations of ischemia (2 or 3 h) in each reperfusion period analysed; *(p < 0.05), **(p < 0.01). ALP alkaline phosphatase, AST aspartate aminotransferase, ALT alanine aminotransferase, CK creatine kinase, LDH lactate dehydrogenase.

Regardless of the duration of ischemia and subsequent reperfusion, the levels of electrolytes analysed (Na+, K+ and Cl) did not vary significantly from reference values (Fig. 2A–C; Table 1). The ischemia/reperfusion process led to an increase in urea and creatinine levels, the indicators of kidney function (Table 1). In the case of urea, a progressive increase was observed throughout the reperfusion process, with a peak after 3 h, with both durations of ischemia (2 h: 65 ± 9.9 mg/dL; 3 h: 68 ± 3.6 mg/dL); reaching 2.3-fold higher than levels in controls (28 ± 3.2 mg/dL; p < 0.001). One hour more of ischemia did not produce significant a change in urea levels (Fig. 2D). In contrast, serum creatinine levels were higher in the animals exposed to a longer duration of ischemia (Fig. 2E; p < 0.05). Specifically, with 2 h of ischemia, the peak was reached after 10 min of reperfusion (0.648 ± 0.19 vs 0.36 ± 0.065 mg/dL in controls; p < 0.05), the level staying high until 3 h, whereas after 3 h of ischemia, creatinine levels continued increasing until a peak of 0.88 ± 0.31 mg/dL at 3 h.

In our experiments, the ischemia/reperfusion was not associated with increases in ALP activity (Fig. 2F). In fact, there were no significant changes in the levels of this enzyme in the animals exposed to 3 h of ischemia, while in those exposed to 2 h of ischemia, levels decreased significantly during the reperfusion period.

Regarding other ubiquitous enzymes, levels of AST and ALT (Fig. 2G,H, Table 1) progressively increased until 3 h; at this point, they started to decrease but did not reach normal levels by 6 h. Though the pattern was similar in the two enzymes, the peak was more dramatic in the case of AST (391.8 ± 72 IU/L) than ALT (90.33 ± 13.19 IU/L).

Levels of CK, a very specific serum marker of muscle damage, followed a very similar pattern to those of AST, with a threefold increase in the first 10 min of reperfusion and a peak at 3 h (Fig. 2I). At all times, the serum levels of this enzyme were significantly higher in animals exposed to 3 h of ischemia rather than 2 h (3-h exposure: 9459 ± 1467 IU/L vs 2-h exposure: 6429 ± 2007 IU/L, p < 0.01). As in the case of AST, CK levels did not reach normal values after 6 h of reperfusion.

Lastly, LDH levels (Fig. 2J, Table 1) also behaved similarly, with levels increasing markedly after just 10 min of reperfusion, reaching levels significantly higher than in controls at this point (44.83 ± 18.81 IU/L), and peaking at 3 h (1395 ± 262.4 IU/L; p < 0.01). In animals subjected to 3 h of ischemia, serum levels of LDH were higher throughout follow-up and did not return to normal after 6 h of reperfusion.

Anatomopathological evaluation of LL-IRI

Twenty-four hours after removal of the tourniquet, the mean upper-thigh girth of the leg exposed to ischemia/reperfusion was 59.5 ± 4.96 mm, 13% larger than that of the other leg (control, 52.25 ± 4.13 mm; p < 0.0001). This increase in girth translates to an estimated 30% increase in the cross-sectional area: 283.5 ± 46.71 mm2 vs 218.6 ± 34.50 mm2 in the control leg (p < 0.0001) (Fig. 3A). Regarding the weight of the gastrocnemius muscle, we observed a nearly 10% increase, with a mean muscle weight of 1.98 ± 0.19 g for the legs exposed to the ischemia vs 1.81 ± 0.14 g for the control legs (p < 0.0001).

Figure 3.

Figure 3

Upper-thigh girth and cross-sectional area of the legs exposed to 3 h of ischemia and 24 h of reperfusion (grey) and the other legs, used as healthy controls (white). Girth and cross-sectional area are expressed in millimetres (mm, left axis) and millimetres squared (mm2, right axis), respectively (A). Representative histological section of a limb subjected to ischemia–reperfusion (the green asterisk indicates an undamaged muscle fibber and the black asterisk shows a muscle fibber damaged by ischemia–reperfusion. The extensive polymorphonuclear cell infiltrate (stained in blue) and oedema between the muscle fibbers (white space) are also seen) (B).

In the microscopic assessment (Fig. 3B), in animals exposed to 3 h of ischemia and 24 h of reperfusion, we observed alterations compatible with IRI-related damage in 65.53 ± 6.86% of fibres in the gastrocnemius muscle. The mean PMN count was 55.28 ± 9.73 cells/field, corresponding to approximately 4.52 × 104 cells/mm2.

Rotarod test

Figure 4 shows the results obtained with the rotarod test. Because of the effects of the anaesthesia used during the ischaemia period, the test could not be performed on the day of the ischaemia (day 0). One day after ischaemia (day + 1, 21.17 ± 7.25 s), a marked decrease in fall latency time was observed, compared to the control, obtained one day before ischaemia (day-1, 199.58 ± 14.75 s; p < 0.0001). Despite a progressive increase in the latency to fall time up to the 10th day (150.5 ± 19.54 s), highly significant differences could still be observed, compared to the pre-ischemia benchmark time. Nevertheless, these differences were no longer observed in the 14th day (186 ± 6.39 s), when the latency to fall time is already similar to the time recorded before the ischaemia.

Figure 4.

Figure 4

Rotarod test. The data shows the mean and standard deviation in the fall time (expressed in seconds) of the animals subjected to 3 h of ischaemia period; ns (p > 0.05), ****(p < 0.0001).

Discussion

Although numerous LL-IRI-related experimental studies have been conducted, the experimental models described in the literature are notably different, there being no consensus on a standard model. The differences are evident in various characteristics of the models including the method of inducing and maintaining the ischemia and the parameters used to assess damage as well as when it is assessed. This diversity makes it very difficult to evaluate the validity and efficacy of treatments tested, and warrants research to identify a model that is reproducible and reliable, as well as easily transferable to clinical practice.

An important question is the choice of the experimental animal. Several considerations have led us to decide in favour of using rats for the research. First, they have more similarities to humans, both in the anatomy of the lower limb muscles having the same muscle groups27,28, and in the tolerance of tissues to ischemia and their response at biochemical and histopathological levels2932. In fact, this is the most widely used animal model in the study of LL-IRI916. It is also a species that is easy to handle and has gentle behaviour and suitable size, facilitating preoperative management and husbandry. Finally, our research group has proven experience in the handling of this species for the study of IRI in other body systems3335.

A second important question for establishing a good IRI model is which type of device or procedure to use to induce and maintain the ischemia. Published studies have used very simple devices, based on a ring or tube, that do not allow measurement of the pressure being applied to maintain the ischemia, and in most cases, apply an excess pressure leading to muscle damage resulting from crushing (crush syndrome), distorting the assessment of damage due to IRI and making the model unlike clinical practice916,36. For this reason, one of the goals of this study was to develop and optimise a mechanical system that imitates the gold standard used in clinical practice, namely, a pneumatic cuff, with which we can induce ischemia using as little pressure possible, and thereby, minimise the damage resulting from the compression.

It is difficult, however, to place a pneumatic cuff on a rat´s leg. First of all, due to the small size of the cuff that would be needed37,38. Further, the truncated cone shape of the leg makes it very difficult to avoid it moving once inflated. To avoid these problems, finally we opted for a system of tension cables, similar in concept to the controlled tension tourniquet described by Bonheur in a murine model18. In mice, 0.2 kg was sufficient to maintain the ischemia; in the case of rats, we have found it necessary to use 1 kg to achieve a suitable level of ischemia. In a previous study of retinal ischemia–reperfusion39 conducted in WAG/RijHsd rats of similar sex, age, and weight to those used in the present study, we determined a mean arterial pressure (MAP) of 126 ± 4.6 mm Hg; in different mouse strains, the MAP ranged from 108 to 114 mm Hg 40. This difference in MAP does not seem to be enough reason to justify a fivefold increase in tensile strength necessary to induce the onset of ischemia in the animals. The most plausible explanation for this difference appears to be simply the difference in size between the two species, but might also be related to the thickness of the cable used. We also believe that the support arms, one to keep the cable stable and one to apply gentle traction to the end of the leg, are useful extra features of our design that allow us to ensure that there are no undesired movements or loss of ischemia.

A third key question is which parameters to use to assess the damage. Among those reported in the literature, we have opted for those which are closest to the parameters used in clinical practice.

A considerable number of clinical studies, mainly focused on assessing the use of anaesthetic drugs to control the damage due to reperfusion immediately after removing a tourniquet, consider the measurement of ischemia modified albumin (IMA), isoprostanes-isofurans and malondialdehyde (MDA)4145. Nonetheless, we believe that the use of these parameters, as well as being expensive, is not easily transferrable to clinical practice. In contrast, both CK and LDH have been widely studied in experimental studies11,14,46,47, are good indicators of rhabdomyolysis and are used in clinical practice4850. In line with these studies, we observed a sudden increase in the levels of both of these enzymes, from the onset of the reperfusion process. Further, their pattern is highly compatible with what Murata et al. described in their crush syndrome model14. In our case, the levels of these two enzymes peaked after 3 h of reperfusion, while other authors11 reported a peak after 4 h. To our mind, it is very interesting that, after a sudden increase immediately after the start of the reperfusion (observed at 10 min) and the levels remaining more or less stable until 60 min, there is a second increase by 3 h. We could speculate that the initial increase after just 10 min seems to be too early to be due to reperfusion. In fact in vitro studies show that skeletal and cardiac muscle fibbers submitted to anoxia release significant amount of LDH and CK51,52.

The rest of the biochemical markers analysed (electrolytes, markers of kidney function and other nonspecific enzymes) have been studied by other authors in different models of lower limb ischemia2,11,14. Findings with our model are fairly similar to their results, in terms of a lack of changes in electrolyte and ALP levels, and slight increases in AST and ALT levels after long periods of reperfusion.

Finally, the markers of kidney damage (urea and creatinine), widely used in IR models, show different patterns. The increase in urea levels continues beyond the period of reperfusion studied, while creatinine increases early on, its levels returning to normal after 6 h.

We should also note that some studies in the literature mention the use of indicators of acid–base balance such as lactate, pH or the anion GAP. These tend to be considered, however, for assessing longer-lasting ischemia and higher compressive forces with potential systemic complications14,53,54, and we have not measured them in our model, which only causes local damage.

Although ischemia does not tend to be induced for longer than 2 h in clinical practice, our observations indicate that with ischemia lasting 3 h, the damage remains local and reversible, as expected30,32,55, although it is obviously increased. For this reason, we believe that 3 h is an ideal duration of ischemia for testing experimental treatments, providing the opportunity to observe any potential protective effects more clearly. In the case of biochemical analysis, based on our own experience and findings of other studies11,14, we believe that measurements should be made after 3 h of reperfusion.

Assessment of histopathological damage is the most controversial and a matter of debate in the literature. While it would be possible to measure substances such as myeloperoxidase, MDA or glutathione by spectrophotometry, this approach is not routinely used in hospitals, and hence, results would be difficult to translate to clinical practice and to interpret, and additionally, the measurements are technically complicated and expensive12,14,15. For this reason, we have again opted for parameters that are more commonly used in clinical practice, in particular, direct assessment of tissue swelling by measuring leg girth, which is easy to perform in patients.

In our model, the swelling present after 24 h of reperfusion increased the upper-thigh cross-sectional area by 30%. This figure is similar to those from a rabbit experimental model56, in which there was a 38% in the cross-sectional area after 4 h of ischemia and 24 h of reperfusion. Regarding the weight of the gastrocnemius muscle, we observed a 10% increase, while Bonheur18 reported a 22% increase, after 3 h of ischemia and 24 h of reperfusion. The difference may be due to Bonheur having used mice, which are a priori more fragile and sensitive.

Other parameters assessed in the literature include histological damage and leukocyte infiltration assessed by microscopy14,17,18,36,56. Our results quantifying microscopic damage, expressed as the percentage of damaged fibres per field, in accordance with the method described by McCormack36, indicate that two-thirds (66%) of fibres were damaged. This is in line with figures reported by other authors, who have found damage in up to 25% of fibres after 90 min17 and 80% after 4 h56 of ischemia. Finally, the PMN count obtained was 4.52 × 104 cell/mm2, consistent with the findings of Deune et al. in a rabbit model with ischemia lasting for 4 h56.

Finally, it is of outmost importance that experimental models translate pathological and biochemical damage into functional impairment or recovery, as this late aspect is what really matter in the clinical setting. In fact, several clinic studies in this field include postoperative mobility indexes or scales6,57,58. Measuring physical activity of animals is not an easy task, but the Rotarod is an acceptably good approximation5962. In fact, we have been able to demonstrate an impairment due to ischemia–reperfusion, which is recovered after an acceptable period of time. This offers another parameter to assess utility of any proposed treatment.

Conclusions

The system for inducing and maintaining the ischemia designed for this study allows us to reliably simulate the damage associated with the use of a pneumatic cuff in clinical practice, especially in orthopaedic surgery.

The biochemical parameters considered, in particular, CK and LDH levels, and measures of tissue damage (swelling, muscle fibre damage and PMN infiltration) have allowed us to define and characterise the LL-IRI-related damage.

Our results enable us to establish a protocol based on 3 h of ischemia and 3 h of reperfusion as a model of LL-IRI which is representative of local damage, similar to that occurring in clinical practice; but lasting more than usual, is more sensitive, facilitating the detection of differences in future studies of prophylactic treatments against LL-IRI.

Materials and methods

All the procedures were carried out in accordance with current legislation and were approved by Experimental Animal Ethical Committee of the University of the Basque Country (ref.: M20/2015/075 HERRERO DE LA PARTE). The study was carried out in compliance with the ARRIVE guidelines.

For this study, we used 3- to 4-month-old male WAG/RijHsd rats, with a mean weight of 302 ± 12 g, bred and housed in the animal facilities at the University of the Basque Country (UPV/EHU). Animals were kept in groups of six in type IV cages (ref. 031,200,126, Harvard Apparatus) with wood shavings (F200017, Courbehaye, France) with food (SAFE A04 SP-10, SAFE Complete Care Competence, Augy, France) and water ad libitum, at a constant temperature of 24 °C under a 12-h:12-h light–dark cycle.

Experimental design

To minimize the influence of circadian variations on the results, all procedures to induce LL-IRI were carried out in the morning. In total, to develop the model and then characterise it, we used 86 animals that were randomised to 11 experimental groups, as shown in Table 2. In all cases, the lower limb subjected to ischemia was the right hind limb.

Table 2.

Experimental groups. Description of experimental groups and animals used in each group.

Group Purpose of the group Number of animals
Pressure Optimisation of pressure used to induce ischemia 20
Control Determination of baseline enzyme levels and normal histological structure 6
IR-1

Biochemical analysis after

2 h of ischaemia and 10 min of reperfusion

6
IR-2

Biochemical analysis after

2 h of ischaemia and 1 h of reperfusion

6
IR-3

Biochemical analysis after

2 h of ischaemia and 3 h of reperfusion

6
IR-4

Biochemical analysis after

2 h of ischaemia and 6 h of reperfusion

6
IR-5

Biochemical analysis after

3 h of ischaemia and 10 min of reperfusion

6
IR-6

Biochemical analysis after

3 h of ischaemia and 1 h of reperfusion

6
IR-7

Biochemical analysis after

3 h of ischaemia and 3 h of reperfusion

6
IR-8

Biochemical analysis after

3 h of ischaemia and 6 h of reperfusion

6
IR-9

Histopathological analysis after

3 h of ischaemia and 24 h of reperfusion

6
IR-10

Rotarod (functional) analysis after

3 h of ischaemia and 14 days of reperfusion

6
Total 86

As a first step, we determined the pressure required to produce and maintain ischemia. For this purpose, after exsanguination of the leg with a rubber bandage, the pressure group (PG) animals were subjected to increasingly higher pressures (0.5, 0.6, 0.7, 0.8, 0.9, 1 kg), until the appearance of clinical signs of ischemia (paleness, coldness) and confirmation of a lack of blood flow in the dorsalis pedis artery, with a Doppler laser probe.

Another group of six animals (the control group, CG) was used to determine both the baseline biochemical parameters and the normal histological structure of the gastrocnemius muscle in the lineage of animals used. The pathophysiological response to LL-IRI at the biochemical level was evaluated in ischemia/reperfusion groups 1 to 8 (IR-1 to IR-8), with different durations of ischemia (2 and 3 h) and reperfusion (10, 60, 180 and 360 min). Finally, the ischemia/reperfusion group 9 (IR-9) allowed us to evaluate the consequences at the histopathological level of LL-IRI (after 3 h of ischemia and 24 h of reperfusion).

System for inducing and maintaining lower limb ischemia

We used a mechanical system developed in-house to induce and maintain ischemia. It includes an adjustable stand allowing the anaesthetized animal to be placed in a supine position. The tourniquet we used to produce the ischemia was made of a 2-mm diameter nylon cable and this was connected to a piston system and a dynamometer (Fig. 5), allowing adjustment of the pressure applied with the tourniquet to the desired level.

Figure 5.

Figure 5

System designed for performing the ischemia. The leg is placed into the loop of the tourniquet (asterisk), adjusting the tensile force with the dynamometer (arrow). The tourniquet is fitted at the top of the thigh with the help of a support arm (lower arrowhead), while the other support arm (upper arrowhead) pulls on the end of the leg.

Anaesthesia and surgical procedure

Animals were anaesthetized using diazepam (15 mg/kg), ketamine (80 mg/kg) and medetomidine (0.5 mg/kg) and placed, supine, on the aforementioned stand. The cable connected to the dynamometer was fixed around the right hind limb, which was held up with a support arm. Once the leg was exsanguinated using a rubber bandage, like an Esmarch bandage (Fig. 6A), the piston was used to tighten the cable to obtain a dynamometer reading of 1 kg and thereby maintain ischemia in the leg (Fig. 6B)41. The conditions were confirmed to be truly ischemic by observing a lack of capillary refill and paleness of the leg (Fig. 6C) and using a Doppler laser probe on the area of the dorsalis pedis artery. Halfway through the ischemia, diazepam was administered again (7.5 mg/kg) to keep the animal sedated until the end of the ischemia. After this time (2 or 3 h, depending on the experimental group), we released the pressure applied by the cable, allowing reperfusion in the leg for the period allocated in each experimental group. Restoration of blood flow was confirmed by the presence of clinical signs, in particular, the sudden onset of reactive hyperaemia. For post-ischemia recovery, the animals were placed in cages with wood shavings under a heat lamp at 22–24 °C and checked every 30 min.

Figure 6.

Figure 6

Procedure for inducing ischemia. Exsanguination of the leg is performed with a rubber bandage (A), the tourniquet is fitted to the base of the leg and the bandage removed (B). It is confirmed that ischemia is maintained by the observation that the leg is pale (C).

Blood sample collection and biochemical analysis

At the end of the reperfusion period, animals were placed in a supine position under inhalation anaesthesia with isoflurane at 1.5%. We performed wide laparotomy and evisceration to identify the inferior vena cava. Once identified, it was dissected, and using a 21G needle, punctured to collect as high a volume of circulating blood as possible (5–7 ml). These procedures imply the death of the animal, though this was ensured by cervical luxation.

The blood obtained was centrifuged at 3000 rpm for 10 min in II SST™ tubes (BD Vacutainer®, New Jersey, USA). The serum obtained was aliquoted and kept at − 25 °C until analysis.

All the biochemical parameters of interest were measured using a Cobas® 8000 c702 modular analyser (Roche Diagnostics GMBH, Mannheim, Germany). Specifically, we measured following: indicators of kidney function (urea and creatinine levels); levels of electrolytes, namely, sodium (Na +), potassium (K +) and chloride (Cl), ubiquitous enzymes, namely, alkaline phosphatase (ALP), aspartate aminotransferase (AST) and alanine aminotransferase (ALT), and lastly muscle enzymes, namely, creatine kinase (CK) and lactate dehydrogenase (LDH).

Anatomopathological analysis

Tissue damage was assessed 24 h after the end of the ischemia, by measuring the girth of both legs (experimental and control) and histological analysis of gastrocnemius muscle sections.

Specifically, to assess the swelling caused by LL-IRI, the hind leg girth was measured at the top of the thigh by wrapping a tape measure around the limb, while the animal was anaesthetized with isoflurane at 1.5%. To standardize the procedure, this measurement was taken after shaving the leg (with an electric shaver), and while the animal was on the stand of the ischemia-inducing system with gentle traction applied to the end of the leg using one of the system’s support arms. We measured upper-thigh girth in both experimental (IR) and control (paired control) legs.

After this, animals were sacrificed under anaesthesia by exsanguination through the abdominal aorta. After checking that animals were dead, the gastrocnemius muscles of both legs were removed, weighed and fixed in formaldehyde at 4%. At least 24 h later, specimens were embedded in paraffin, and subsequently, they were sliced into 3-µm histological sections which were stained with haematoxylin/eosin for histological analysis.

Tissue damage was assessed by counting the number of muscle fibres damaged with respect to the total number of fibres observed in five randomly selected fields36. We also assessed polymorphonuclear neutrophil (PMN) infiltration, by counting the number of these cells in each field.

Rotarod test

Six rats were tested on a Rotarod apparatus (Panlab Hardvard Apparatus, Barcelona, Spain). The rats were placed on a moving rod with a rotation speed of 15 rpm. Following the 15 s acclimation time, the Rotarod was gradually accelerated on a 30-s slope, which increased the speed from 15 to 25 rpm.

Once the rod acceleration started, the latency to fall time started to be recorded automatically by the SeDaCom v2.0.03 software (Panlab Hardvard Apparatus, Barcelona, Spain); the speed of the rotarod at the time of fall was also recorded. Prior to ischemia induction, animals were subjected to a 2-day training protocol before being tested on the day -1, which acclimated the rats to the rotarod. The animals were subjected to the Rotarod test every day during the first week after ischemia, and also on day 10 and day 14.

Statistical analysis

The statistical analysis was carried out using Prism® 7 software (GraphPad Software, San Diego CA, USA). First, the Kolmogorov–Smirnov test was used to check the distribution of the data. Having confirmed that data were normally distributed, the results were expressed as means and standard deviations (SDs), and between-group comparisons were performed with parametric tests.

Comparisons between legs subjected to ischemia/reperfusion and the controls were made using the Student’s t-test for paired samples, while comparisons between the different experimental groups were made using analysis of variance (ANOVA) and the Newman-Keuls post-hoc test. In all the analyses, p values < 0.05 were considered statistically significant.

Author contributions

I.C. and I.G.A. conceptualized and designed the project. I.C. acquired, analysed, and interpreted the data. I.C. and B.H.P. wrote the draft. I.C., B.H.P., D.I.M.F. and I.G.A. substantively revised the manuscript. All authors have read and approved the final submitted manuscript.

Funding

No external funding was received. This study has been supported by internal funding from the Department of the Surgery, Radiology and Physical Medicine at the University of the Basque Country (UPV/EHU).

Competing interests

The authors declare no competing interests.

Footnotes

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  • 1.Haglund U, Lundgren O. Intestinal ischemia and shock factors. Fed. Proc. 1978;37:2729–2733. [PubMed] [Google Scholar]
  • 2.Blaisdell FW. The pathophysiology of skeletal muscle ischemia and the reperfusion syndrome: A review. Cardiovasc. Surg. 2002;10:620–630. doi: 10.1016/S0967-2109(02)00070-4. [DOI] [PubMed] [Google Scholar]
  • 3.Saied A, Zyaei A. Tourniquet use during plating of acute extra-articular tibial fractures: Effects on final results of the operation. J. Trauma. 2010;69:E94–E97. doi: 10.1097/TA.0b013e3181dbac93. [DOI] [PubMed] [Google Scholar]
  • 4.Konrad G, Markmiller M, Lenich A, Mayr E, Rüter A. Tourniquets may increase postoperative swelling and pain after internal fixation of ankle fractures. Clin. Orthop. Relat. Res. 2005 doi: 10.1097/01.blo.0000151849.37260.0a. [DOI] [PubMed] [Google Scholar]
  • 5.Kirkley A, et al. Tourniquet versus no tourniquet use in routine knee arthroscopy: A prospective, double-blind, randomized clinical trial. Arthroscopy. 2000;16:121–126. doi: 10.1016/S0749-8063(00)90024-0. [DOI] [PubMed] [Google Scholar]
  • 6.Ejaz A, et al. Faster recovery without the use of a tourniquet in total knee arthroplasty. Acta Orthop. 2014;85:422–426. doi: 10.3109/17453674.2014.931197. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Liu D, Graham D, Gillies K, Gillies RM. Effects of tourniquet use on quadriceps function and pain in total knee arthroplasty. Knee Surg. Relat. Res. 2014;26:207–213. doi: 10.5792/ksrr.2014.26.4.207. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Dennis DA, et al. Does tourniquet use in TKA affect recovery of lower extremity strength and function? A randomized trial. Clin. Orthop. Relat. Res. 2016;474:69–77. doi: 10.1007/s11999-015-4393-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Kocman EA, et al. Effects of ischemic preconditioning protocols on skeletal muscle ischemia-reperfusion injury. J. Surg. Res. 2015;193:942–952. doi: 10.1016/j.jss.2014.09.032. [DOI] [PubMed] [Google Scholar]
  • 10.Wang WZ, et al. Microcirculatory effects of melatonin in rat skeletal muscle after prolonged ischemia. J. Pineal Res. 2005;39:57–65. doi: 10.1111/j.1600-079X.2005.00215.x. [DOI] [PubMed] [Google Scholar]
  • 11.Sagara G, et al. Comparison of effects of ischemia period in rat limb ischemia/reperfusion injury. Nagoya Med. J. 2009;50:83–91. [Google Scholar]
  • 12.Dillon JP, et al. Pravastatin attenuates tourniquet-induced skeletal muscle ischemia reperfusion injury. Acta Orthop. 2006;77:27–32. doi: 10.1080/17453670610045669. [DOI] [PubMed] [Google Scholar]
  • 13.Duarte JA, et al. Administration of tourniquet. I. Are edema and oxidative stress related to each other and to the duration of ischemia in reperfused skeletal muscle? Arch. Orthop. Trauma Surg. 1997;116:97–100. doi: 10.1007/BF00434110. [DOI] [PubMed] [Google Scholar]
  • 14.Murata I, et al. Characterization of systemic and histologic injury after crush syndrome and intervals of reperfusion in a small animal model. J. Trauma Acute Care Surg. 2011;70:2. doi: 10.1097/TA.0b013e31820ca00a. [DOI] [PubMed] [Google Scholar]
  • 15.Köksoy C, et al. Simvastatin pretreatment reduces the severity of limb ischemia in an experimental diabetes model. J. Vasc. Surg. 2007;45:590–596. doi: 10.1016/j.jvs.2006.10.048. [DOI] [PubMed] [Google Scholar]
  • 16.Ergün Y, Kılınç M, Aral M, Hedef A, Kaya E. Protective effect of epigallocatechin gallate in ischemia-reperfusion injury of rat skeletal muscle. J. Surg. Res. 2020;247:1–7. doi: 10.1016/j.jss.2019.11.004. [DOI] [PubMed] [Google Scholar]
  • 17.Crawford RS, et al. A novel model of acute murine hindlimb ischemia. Am. J. Physiol. Circ. Physiol. 2007;292:H830–H837. doi: 10.1152/ajpheart.00581.2006. [DOI] [PubMed] [Google Scholar]
  • 18.Bonheur JA, Albadawi H, Patton GM, Watkins MT. A noninvasive murine model of hind limb ischemia-reperfusion injury. J. Surg. Res. 2004;116:55–63. doi: 10.1016/S0022-4804(03)00232-4. [DOI] [PubMed] [Google Scholar]
  • 19.Drysch M, et al. An optimized low-pressure tourniquet murine hind limb ischemia reperfusion model: Inducing acute ischemia reperfusion injury in C57BL/6 wild type mice. PLoS ONE. 2019;14:e0210961–e0210961. doi: 10.1371/journal.pone.0210961. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Masri BA, Eisen A, Duncan CP, McEwen JA. Tourniquet-induced nerve compression injuries are caused by high pressure levels and gradients—a review of the evidence to guide safe surgical, pre-hospital and blood flow restriction usage. BMC Biomed. Eng. 2020;2:7. doi: 10.1186/s42490-020-00041-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Vaughan A, Hardwick T, Gaskin J, Bendall S. Tourniquet use in orthopaedic surgery. Orthop. Trauma. 2017;31:312–315. doi: 10.1016/j.mporth.2017.07.010. [DOI] [Google Scholar]
  • 22.Hu J, et al. Mortality and morbidity associated with simultaneous bilateral or staged bilateral total knee arthroplasty: A meta-analysis. Arch. Orthop. Trauma Surg. 2011;131:1291–1298. doi: 10.1007/s00402-011-1287-4. [DOI] [PubMed] [Google Scholar]
  • 23.Makaram NS, Roberts SB, Macpherson GJ. Simultaneous bilateral total knee arthroplasty is associated with shorter length of stay but increased mortality compared with staged bilateral total knee arthroplasty: A systematic review and meta-analysis. J. Arthroplasty. 2021 doi: 10.1016/j.arth.2021.01.045. [DOI] [PubMed] [Google Scholar]
  • 24.Fu D, et al. Comparison of clinical outcome between simultaneous-bilateral and staged-bilateral total knee arthroplasty: A systematic review of retrospective studies. J. Arthroplasty. 2013;28:1141–1147. doi: 10.1016/j.arth.2012.09.023. [DOI] [PubMed] [Google Scholar]
  • 25.McNutt M. Reproducibility. Science. 2014;343:229. doi: 10.1126/science.1250475. [DOI] [PubMed] [Google Scholar]
  • 26.Samsa G, Samsa L. A guide to reproducibility in preclinical research. Acad. Med. 2019;94:47–52. doi: 10.1097/ACM.0000000000002351. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Greene EC. Anatomy of the rat. Trans. Am. Philos. Soc. 1935;27:1–370. doi: 10.2307/1005513. [DOI] [Google Scholar]
  • 28.Weber B, et al. Modeling trauma in rats: similarities to humans and potential pitfalls to consider. J. Transl. Med. 2019;17:305. doi: 10.1186/s12967-019-2052-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Gillani S, Cao J, Suzuki T, Hak DJ. The effect of ischemia reperfusion injury on skeletal muscle. Injury. 2012;43:670–675. doi: 10.1016/j.injury.2011.03.008. [DOI] [PubMed] [Google Scholar]
  • 30.Rorabeck CH. Tourniquet-induced nerve ischemia: An experimental investigation. J. Trauma Acute Care Surg. 1980;20:2. doi: 10.1097/00005373-198004000-00002. [DOI] [PubMed] [Google Scholar]
  • 31.Nitz AJ, Dobner JJ, Matulionis DH. Pneumatic tourniquet application and nerve integrity: Motor function and electrophysiology. Exp. Neurol. 1986;94:264–279. doi: 10.1016/0014-4886(86)90101-9. [DOI] [PubMed] [Google Scholar]
  • 32.Heppenstall RB, Scott R, Sapega A, Park YS, Chance B. A comparative study of the tolerance of skeletal muscle to ischemia. Tourniquet application compared with acute compartment syndrome. J. Bone Jt. Surg. 1986;68:2. doi: 10.2106/00004623-198668060-00004. [DOI] [PubMed] [Google Scholar]
  • 33.Portugal V, García-Alonso I, Barceló P, Méndez J. Effect of allopurinol, folinic acid, sod and cyclosporine a on ischemic liver regeneration. Eur. Surg. Res. 1995;27:69–76. doi: 10.1159/000129375. [DOI] [PubMed] [Google Scholar]
  • 34.Bilbao JE, et al. Therapeutic usefulness of antioxidant drugs in experimental intestinal reperfusion syndrome. Rev. Esp. Enferm. Dig. 1991;80:237–241. [PubMed] [Google Scholar]
  • 35.San Cristóbal J, et al. Capillary blood flown as an index of the therapeutic effect of folinic acid in ischemia-reperfusion syndrome. Rev. Española Enfermedades Digest. 2007;99:25–32. doi: 10.4321/s1130-01082007000100006. [DOI] [PubMed] [Google Scholar]
  • 36.McCormack MC, et al. Development of reproducible histologic injury severity scores: Skeletal muscle reperfusion injury. Surgery. 2008;143:126–133. doi: 10.1016/j.surg.2007.06.005. [DOI] [PubMed] [Google Scholar]
  • 37.McEwen JA, Kelly DL, Jardanowski T, Inkpen K. Tourniquet safety in lower leg applications. Orthop. Nurs. 2002;21:2. doi: 10.1054/joon.2001.0224. [DOI] [PubMed] [Google Scholar]
  • 38.Pedowitz RA, et al. The use of lower tourniquet inflation pressures in extremity surgery facilitated by curved and wide tourniquets and an integrated cuff inflation system. Clin. Orthop. Relat. Res. 1993;287:237–244. [PubMed] [Google Scholar]
  • 39.San Cristóbal Epalza J, Palomares T, García-Alonso I, Herrero de la Parte B. Histological assessment of rat retinas with ischemia-reperfusion injury. Eur. Surg. Res. 2021 doi: 10.1159/000515832. [DOI] [PubMed] [Google Scholar]
  • 40.Mattson DL. Comparison of arterial blood pressure in different strains of mice. Am. J. Hypertens. 2001;14:405–408. doi: 10.1016/S0895-7061(00)01285-1. [DOI] [PubMed] [Google Scholar]
  • 41.Mas E, et al. Effects of spinal or general anesthesia on F2-isoprostanes and isofurans during ischemia/reperfusion of the leg in patients undergoing knee replacement surgery. Free Radic. Biol. Med. 2011;50:1171–1176. doi: 10.1016/j.freeradbiomed.2011.01.021. [DOI] [PubMed] [Google Scholar]
  • 42.Erturk E, et al. Comparison of the effect of propofol and N-acetyl cysteine in preventing ischaemia–reperfusion injury. Eur. J. Anaesthesiol. 2009;26:279–284. doi: 10.1097/EJA.0b013e32831c87c7. [DOI] [PubMed] [Google Scholar]
  • 43.Aldemir O, Celebi H, Cevik C, Duzgun E. The effects of propofol or halothane on free radical production after tourniquet induced ischaemia-reperfusion injury during knee arthroplasty. Acta Anaesthesiol. Scand. 2001;45:1221–1225. doi: 10.1034/j.1399-6576.2001.451008.x. [DOI] [PubMed] [Google Scholar]
  • 44.Turan R, Yagmurdur H, Kavutcu M, Dikmen B. Propofol and tourniquet induced ischaemia reperfusion injury in lower extremity operations. Eur. J. Anaesthesiol. 2007;24:185–189. doi: 10.1017/S0265021506001347. [DOI] [PubMed] [Google Scholar]
  • 45.Yagmurdur H, et al. Dexmedetomidine reduces the ischemia-reperfusion injury markers during upper extremity surgery with tourniquet. J. Hand Surg. Am. 2008;33:941–947. doi: 10.1016/j.jhsa.2008.01.014. [DOI] [PubMed] [Google Scholar]
  • 46.Heppenstall RB, Balderston R, Goodwin C. Pathophysiologic effects distal to a tourniquet in the dog. J. Trauma Acute Care Surg. 1979;19:2. doi: 10.1097/00005373-197904000-00003. [DOI] [PubMed] [Google Scholar]
  • 47.Chiu D, Wang HH, Blumenthal MR. Creatine phosphokinase release as a measure of tourniquet effect on skeletal muscle. Arch. Surg. 1976;111:71–74. doi: 10.1001/archsurg.1976.01360190073013. [DOI] [PubMed] [Google Scholar]
  • 48.Smith J, Greaves I. Crush injury and crush syndrome: A review. J. Trauma Acute Care Surg. 2003;54:2. doi: 10.1097/01.TA.0000047203.00084.94. [DOI] [PubMed] [Google Scholar]
  • 49.Malinoski DJ, Slater MS, Mullins RJ. Crush injury and rhabdomyolysis. Crit. Care Clin. 2004;20:171–192. doi: 10.1016/S0749-0704(03)00091-5. [DOI] [PubMed] [Google Scholar]
  • 50.Russell TA. Acute renal failure related to rhabdomyolysis: Pathophysiology, diagnosis, and collaborative management. Nephrol. Nurs. J. 2006;27:567. [PubMed] [Google Scholar]
  • 51.Fredsted A, Mikkelsen UR, Gissel H, Clausen T. Anoxia induces Ca2+ influx and loss of cell membrane integrity in rat extensor digitorum longus muscle. Exp. Physiol. 2005;90:703–714. doi: 10.1113/expphysiol.2005.030247. [DOI] [PubMed] [Google Scholar]
  • 52.Hearse DJ, Humphrey SM. Enzyme release during myocardial anoxia: A study of metabolic protection. J. Mol. Cell. Cardiol. 1975;7:463–482. doi: 10.1016/0022-2828(75)90164-9. [DOI] [PubMed] [Google Scholar]
  • 53.Müller M, et al. Key metabolite kinetics in human skeletal muscle during ischaemia and reperfusion: Measurement by microdialysis. Eur. J. Clin. Invest. 1995;25:601–607. doi: 10.1111/j.1365-2362.1995.tb01752.x. [DOI] [PubMed] [Google Scholar]
  • 54.Korth MD, U., et al. Tourniquet-induced changes of energy metabolism in human skeletal muscle monitored by microdialysis. Anesthesiol. J. Am. Soc. Anesthesiol. 2000;93:1407–1412. doi: 10.1097/00000542-200012000-00011. [DOI] [PubMed] [Google Scholar]
  • 55.Day RL, Zale BW. The effect of tourniquets on muscle enzymes during foot and ankle surgery. J. Foot Ankle Surg Off. Publ. Am. Coll. Foot Ankle Surg. 1993;32:280–285. [PubMed] [Google Scholar]
  • 56.Deune GE, et al. Prevention of ischemia-reperfusion injury with a synthetic metalloprotein superoxide dismutase mimic, SC52608. Plast. Reconstr. Surg. 1996;98:2. doi: 10.1097/00006534-199609001-00018. [DOI] [PubMed] [Google Scholar]
  • 57.Alexandersson M, Wang EY, Eriksson S. A small difference in recovery between total knee arthroplasty with and without tourniquet use the first 3 months after surgery: A randomized controlled study. Knee Surg. Sport. Traumatol. Arthrosc. 2019;27:1035–1042. doi: 10.1007/s00167-018-5196-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Mowafi HA, Ismail SA. Melatonin improves tourniquet tolerance and enhances postoperative analgesia in patients receiving intravenous regional anesthesia. Anesth. Analg. 2008;107:2. doi: 10.1213/ane.0b013e318181f689. [DOI] [PubMed] [Google Scholar]
  • 59.Garbaisz D, et al. Attenuation of skeletal muscle and renal injury to the lower limb following ischemia-reperfusion using mPTP inhibitor NIM-811. PLoS ONE. 2014;9:e101067. doi: 10.1371/journal.pone.0101067. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Deacon RMJ. Measuring motor coordination in mice. J. Vis. Exp. 2013;2:e2609–e2609. doi: 10.3791/2609. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Díaz D, et al. Bone marrow transplantation improves motor activity in a mouse model of ataxia. J. Tissue Eng. Regen. Med. 2018;12:e1950–e1961. doi: 10.1002/term.2626. [DOI] [PubMed] [Google Scholar]
  • 62.Graber TG, Ferguson-Stegall L, Kim J-H, Thompson LV. C57BL/6 neuromuscular healthspan scoring system. J. Gerontol. A. Biol. Sci. Med. Sci. 2013;68:1326–1336. doi: 10.1093/gerona/glt032. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Scientific Reports are provided here courtesy of Nature Publishing Group

RESOURCES